A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaci.2008.04.005PMID 18539196PMCID PMC2821937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• From The Cover : Identification of mast cell progenitors in adult mice

  2007cited by this paper
• Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation*

  2007cited by this paper
• Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1

  2007cited by this paper
• IL‐33 is a chemoattractant for human Th2 cells

  2007cited by this paper
• IL-33 can promote survival, adhesion and cytokine production in human mast cells

  2007cited by this paper
• Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis.

  2005cited by this paper
• Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions.

  2005cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005influential reference
• Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

  2003cited by this paper
• Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: I. Loss of Membrane IL-5 Receptor α on Airway Eosinophils and Increased Soluble IL-5 Receptor α in the Airway After Allergen Challenge1

  2002cited by this paper
• Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge.

  2002influential reference
• A new nomenclature for IL-1-family genes.

  2001cited by this paper
• Eosinophil cytokines.

  2000cited by this paper
• T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses

  2000cited by this paper
• Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

  2000cited by this paper
• Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses

  1999cited by this paper
• Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG.

  1999cited by this paper
• Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells

  1998cited by this paper
• Eotaxin is required for the baseline level of tissue eosinophils.

  1998cited by this paper
• T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.

  1998cited by this paper
• The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors.

  1998cited by this paper
• Interleukin-1.

  1997cited by this paper
• CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.

  1994cited by this paper
• Release of granule proteins from eosinophils cultured with IL-5.

  1992cited by this paper
• Recombinant human interleukin 5 is a selective activator of human eosinophil function

  1988cited by this paper
• [Biology of eosinophils].

  1978influential reference

• IL-33 blockade attenuates vascular inflammation in a mouse model of Kawasaki disease vasculitis.

  2026cites this paper
• Exploring the Potential Role of Interleukin-33 in Inducing Eosinophil-Mediated Fibrosis in Hepatic Alveolar Echinococcosis.

  2026cites this paper
• IL‐33 Elicits LTC4 Synthesis in Allergic Inflammation via ST2‐Mediated Activation of Eosinophils

  2026cites this paper
• Eosinophil Biology Today-A Primer for Basic and Clinical Investigators.

  2026cites this paper
• Current Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps

  2025cites this paper
• TSLPR deficiency attenuates AHR independently of eosinophilia and mucus secretion in a chronic HDM mouse model of allergic asthma

  2025cites this paper
• Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities

  2025cites this paper
• Touching a Nerve: Neuroimmune Interactions in Asthma

  2025cites this paper
• Targeting alarmins in asthma- From the bench to the clinic.

  2025cites this paper
• Role of the interleukin-33 (IL-33)/ suppressor of tumorigenicity 2 (ST2) signaling in superoxide anion-triggered inflammation and pain behavior in mice.

  2025cites this paper
• IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential

  2025cites this paper
• The role of interleukin-33 in inflammatory diseases of the nasal cavity

  2025cites this paper
• Eosinophils enhance granuloma-mediated control of persistent Salmonella infection in mice

  2025cites this paper
• Biological mechanisms and therapeutic prospects of interleukin-33 in pathogenesis and treatment of allergic disease

  2025cites this paper
• Assessment of in vitro interactions between eosinophils and cancer cells by imaging-enhanced flow cytometry and time lapse microscopy.

  2025cites this paper
• Eosinophils Enhance Granuloma-Mediated Control of Persistent Salmonella Infection

  2025cites this paper
• Epithelial-derived cytokines in the pathogenesis of severe asthma

  2025cites this paper
• Dietary fiber is a critical determinant of pathologic ILC2 responses and intestinal inflammation

  2024cites this paper
• Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles

  2024cites this paper
• Interplay of cytokines in the pathophysiology of atopic dermatitis: insights from Murin models and human

  2024cites this paper
• Endotyping Eosinophilic Inflammation in COPD with ELAVL1, ZfP36 and HNRNPD mRNA Genes

  2024influential citation
• Investigation of LTF mRNA expression levels as an anti-T2 asthma biomarker.

  2024cites this paper
• Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators

  2024cites this paper
• The last step to achieve barrier damage control

  2024cites this paper
• Repeated sensitization of mice with microfilariae of Litomosoides sigmodontis induces pulmonary eosinophilia in an IL-33-dependent manner

  2024cites this paper
• Cobrotoxin, a single peptide from snake venom, ameliorates atopic dermatitis via suppression of MK2 modulated by IgE and IL-33

  2024cites this paper
• Eosinophil-Epithelial Cell Interactions in Asthma

  2024cites this paper
• The emerging role of alarmin-targeting biologics in the treatment of patients with COPD.

  2024cites this paper
• New possibilities of allergen-specific immunotherapy in relation to the induction of antiviral immunity in patients with bronchial asthma

  2024cites this paper
• Inflammatory profile of eosinophils in asthma-COPD overlap and eosinophilic COPD: a multi-omics study

  2024cites this paper
• Eosinophil-Airway Epithelial Cells crosstalk reveals the eosinophils-mediated DUOX1 up-regulation in a murine allergic inflammation setting.

  2024cites this paper
• LKB1 prevents ILC2 exhaustion to enhance antitumor immunity.

  2024cites this paper
• Interleukin-33: A Double-Edged Sword in Sepsis

  2024cites this paper
• Prospective study on the association between 36 human blood cell traits and pan-cancer outcomes: a mendelian randomization analysis

  2024cites this paper
• Complementary methods for the study of interactions between eosinophils and cancer cells

  2024cites this paper
• Development and dysfunction of structural cells in eosinophilic esophagitis.

  2024cites this paper
• Stromal cell and B cell dialogue potentiates IL-33-enriched lymphoid niches to support eosinophil recruitment and function during type 2 immunity.

  2024cites this paper
• Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease.

  2024cites this paper
• Eosinophil Specialization Is Regulated by Exposure to the Esophageal Epithelial Microenvironment.

  2024cites this paper
• Innate Type-2 Cytokines: From Immune Regulation to Therapeutic Targets

  2024cites this paper
• ATP functions as a primary alarmin in allergen-induced type 2 immunity.

  2023cites this paper
• Cutaneous adverse drug reactions.

  2023cites this paper
• Comparison of IL-33 and IL-5 Family Mediated Activation of Human Eosinophils

  2023cites this paper
• IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma.

  2023cites this paper
• A review of the pathophysiology and the role of ion channels on bronchial asthma

  2023cites this paper
• Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction

  2023cites this paper
• Eosinophils in obesity and obesity-associated disorders

  2023cites this paper
• Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook.

  2023cites this paper
• Alarmins - novel targets for biological therapy

  2023cites this paper
• The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy

  2023cites this paper
• Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction

  2023cites this paper
• Role of IL-33 and IL-35 in the Pathogenesis of Rheumatoid Arthritis

  2023cites this paper
• Gastric alarmin release: A warning signal in the development of gastric mucosal diseases

  2022cites this paper
• Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response

  2022cites this paper
• Dokumentation von Biologika-Therapien bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP): Dupilumab, Omalizumab und Mepolizumab

  2022influential citation
• Low CC16 mRNA Expression Levels in Bronchial Epithelial Cells Are Associated with Asthma Severity.

  2022cites this paper
• Blockade of interleukin-33 activities by recombinant interleukin-33 Trap Fc protein would be a novel therapeutic strategy in allergic asthma

  2022cites this paper
• Human differentiated eosinophils release IL-13 in response to IL-33 stimulation

  2022cites this paper
• Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)

  2022cites this paper
• Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related disease

  2022cites this paper
• Indicating biologics for chronic rhinosinusitiswith nasal polyps (CRSwNP) Recommendations by German allergy and ORL societies AeDA and DGHNO for dupilumab, omalizumab, andmepolizumab

  2022cites this paper
• Small intestinal resident eosinophils maintain gut homeostasis following microbial colonization.

  2022cites this paper
• IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells

  2022cites this paper
• Betuletol, a Propolis Component, Suppresses IL-33 Gene Expression and Effective against Eosinophilia

  2022cites this paper
• IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma

  2022cites this paper
• The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4+ eosinophils unique to the small intestine

  2022cites this paper
• Targeting downstream type 2 cytokines or upstream epithelial alarmins for severe asthma.

  2022cites this paper
• Targeting the Epithelium-Derived Innate Cytokines: From Bench to Bedside

  2022influential citation
• High Mobility Group Box-1 Protein and Interleukin 33 Expression in Allergic Rhinitis

  2022cites this paper
• Involvement of IL-33 in the Pathophysiology of Systemic Lupus Erythematosus: Review

  2022cites this paper
• The Role of Airway Epithelial Cell Alarmins in Asthma

  2022cites this paper
• Molecular anatomy of eosinophil activation by IL5 and IL33

  2022cites this paper
• IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.

  2022cites this paper
• Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies

  2022cites this paper
• Sounding the alarmins—The role of alarmin cytokines in asthma

  2022cites this paper
• Rethinking neutrophils and eosinophils in chronic rhinosinusitis.

  2021cites this paper
• The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention.

  2021cites this paper
• Bidirectional Crosstalk Between Eosinophils and Esophageal Epithelial Cells Regulates Inflammatory and Remodeling Processes

  2021cites this paper
• Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production

  2021cites this paper
• 12/15-Lipoxygenase Regulates IL-33-Induced Eosinophilic Airway Inflammation in Mice

  2021cites this paper
• First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

  2021cites this paper
• Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice

  2021cites this paper
• Could Interleukin-33 (IL-33) Govern the Outcome of an Equine Influenza Virus Infection? Learning from Other Species

  2021cites this paper
• Sphagneticola trilobata (L.) Pruski-derived kaurenoic acid prevents ovalbumin-induced asthma in mice: Effect on Th2 cytokines, STAT6/GATA-3 signaling, NFκB/Nrf2 redox sensitive pathways, and regulatory T cell phenotype markers.

  2021cites this paper
• IL-33, IL-37, and Vitamin D Interaction Mediate Immunomodulation of Inflammation in Degenerating Cartilage

  2021cites this paper
• Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma

  2021cites this paper
• Environmental Allergens Trigger Type 2 Inflammation Through Ripoptosome Activation

  2021cites this paper
• The New Era of Biologics in Atopic Dermatitis: A Review

  2021cites this paper
• Novel pathogenesis of atopic dermatitis from the view of cytokines in mice and humans.

  2021cites this paper
• The Enigma of Eosinophil Degranulation

  2021cites this paper
• Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time

  2021cites this paper
• NFκB1 Dichotomously Regulates Pro-Inflammatory and Antiviral Responses in Asthma

  2021cites this paper
• Immunological background for treatments with biologicals in CRSwNP

  2021cites this paper
• T2-Inflammation bei entzündlichen Atemwegserkrankungen: Grundlage neuer Behandlungsoptionen

  2021cites this paper
• The role of interleukin-33 in the pathogenesis, and treatment of severe asthma

  2021cites this paper
• Role of eosinophilia in IgG4-related disease.

  2021cites this paper
• The Pathology of Type 2 Inflammation-Associated Itch in Atopic Dermatitis

  2021cites this paper
• The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome

  2020cites this paper
• Blocking Interleukin-33 Alleviates the Joint Inflammation and Inhibits the Development of Collagen-Induced Arthritis in Mice

  2020cites this paper
• The emerging role of type 2 inflammation in asthma

  2020cites this paper